{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:18:23Z","timestamp":1771921103612,"version":"3.50.1"},"reference-count":99,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Epidermolysis bullosa (EB) includes a group of rare skin diseases characterized by skin fragility with bullous formation in the skin, in response to minor mechanical injury, as well as varying degrees of involvement of the mucous membranes of the internal organs. EB is classified into simplex, junctional, dystrophic and mixed. The impact of the disease on patients is both physical and psychological, with the result that their quality of life is constantly affected. Unfortunately, there are still no approved treatments available to confront the disease, and treatment focuses on improving the symptoms with topical treatments to avoid complications and other infections. Stem cells are undifferentiated cells capable of producing, maintaining and replacing terminally differentiated cells and tissues. Stem cells can be isolated from embryonic or adult tissues, including skin, but are also produced by genetic reprogramming of differentiated cells. Preclinical and clinical research has recently greatly improved stem cell therapy, making it a promising treatment option for various diseases in which current medical treatments fail to cure, prevent progression, or alleviate symptoms. So far, stem cells from different sources, mainly hematopoietic and mesenchymal, autologous or heterologous have been used for the treatment of the most severe forms of the disease each one of them with some beneficial effects. However, the mechanisms through which stem cells exert their beneficial role are still unknown or incompletely understood and most importantly further research is required to evaluate the effectiveness and safety of these treatments. The transplantation of skin grafts to patients produced by gene-corrected autologous epidermal stem cells has been proved to be rather successful for the treatment of skin lesions in the long term in a limited number of patients. Nevertheless, these treatments do not address the internal epithelia-related complications manifested in patients with more severe forms.<\/jats:p>","DOI":"10.3390\/bioengineering10040422","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T07:32:09Z","timestamp":1679902329000},"page":"422","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Stem Cell Therapies for Epidermolysis Bullosa Treatment"],"prefix":"10.3390","volume":"10","author":[{"given":"Argyrw","family":"Niti","sequence":"first","affiliation":[{"name":"Biohellenika Biotechnology Company, Leoforos Georgikis Scholis 65, GR 555 35 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Koliakos","sequence":"additional","affiliation":[{"name":"Biohellenika Biotechnology Company, Leoforos Georgikis Scholis 65, GR 555 35 Thessaloniki, Greece"},{"name":"Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, GR 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-9370","authenticated-orcid":false,"given":"Anna","family":"Michopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, GR 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"ref_1","first-page":"390","article-title":"Anatomy, histology and immunohistochemistry of normal human skin","volume":"12","author":"Kanitakis","year":"2002","journal-title":"Eur. J. Dermatol."},{"key":"ref_2","unstructured":"Gawkrodger, D.J. (2002). Dermatology\u2014An Illustrated Colour Text, Churchill Livingstone. [3rd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"179784","DOI":"10.1155\/2013\/179784","article-title":"Skin Basement Membrane: The Foundation of Epidermal Integrity\u2014BM Functions and Diverse Roles of Bridging Molecules Nidogen and Perlecan","volume":"2013","author":"Breitkreutz","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"a004911","DOI":"10.1101\/cshperspect.a004911","article-title":"Basement Membranes: Cell Scaffoldings and Signaling Platforms","volume":"3","author":"Yurchenco","year":"2011","journal-title":"Cold Spring Harb. Perspect Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0945-053X(98)00004-3","article-title":"Laminins of the dermo-epidermal junction","volume":"18","author":"Aumailley","year":"1999","journal-title":"Matrix. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1523-1747.1999.00546.x","article-title":"Structure and function of hemidesmosomes: More than simple adhesion complexes","volume":"112","author":"Borradori","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/1523-1747.ep12475433","article-title":"Bullous pemphigoid antigen: cDNA cloning, cellular expression, and evidence for polymorphism of the human gene","volume":"96","author":"Sawamura","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(91)90092-D","article-title":"Epiligrin, a new cell adhesion ligand for integrin \u03b13\u03b21 in epithelial basement membranes","volume":"65","author":"Carter","year":"1991","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.114.3.567","article-title":"Kalinin: An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments","volume":"114","author":"Rousselle","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_10","first-page":"255","article-title":"Inherited epidermolysis bullosa\u2014The spectrum of complications","volume":"19","author":"Husar","year":"2011","journal-title":"Acta Derm. Croat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/07853890.2013.866441","article-title":"Inherited blistering skin diseases: Underlying molecular mechanisms and emerging therapies","volume":"46","author":"Salam","year":"2014","journal-title":"Ann. Med."},{"key":"ref_12","first-page":"21","article-title":"Heredit\u00e4re Anlage zur Blasenbildung (Epidermolysis bullosa hereditaria)","volume":"12","year":"1886","journal-title":"Aus. Poliklin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/jid.1962.156","article-title":"Studies on the pathogenesis of Epidermolysis bullosa","volume":"39","author":"Pearson","year":"1962","journal-title":"J. Invest. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5021\/ad.2015.27.6.658","article-title":"Recently Identified Forms of Epidermolysis Bullosa","volume":"27","author":"McGrath","year":"2015","journal-title":"Ann. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2133.1954.tb12605.x","article-title":"Epidermolysis bullosa resembling juvenile dermatitis herpetiformis","volume":"66","author":"Dowling","year":"1954","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI38177","article-title":"Epidermolysis bullosa simplex: A paradigm for disorders of tissue fragility","volume":"119","author":"Coulombe","year":"2009","journal-title":"J. Clin. Invest."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/cam.23132","article-title":"Laminin 332 processing impacts cellular behavior","volume":"7","author":"Rousselle","year":"2013","journal-title":"Cell. Adh. Migr."},{"key":"ref_19","unstructured":"Rousselle, P., and Michopoulou, A. (2015). Blistering Disease, Springer. Available online: http:\/\/link.springer.com\/10.1007\/978-3-662-45698-9_9."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/ddg234","article-title":"An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome","volume":"12","author":"McLean","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0945-053X(98)00007-9","article-title":"Biology of anchoring fibrils: Lessons from dystrophic epidermolysis bullosa","volume":"18","year":"1999","journal-title":"Matrix. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1600-0625.2008.00723.x","article-title":"Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa","volume":"17","author":"Dang","year":"2008","journal-title":"Exp. Dermatol."},{"key":"ref_23","first-page":"1737","article-title":"Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers","volume":"12","author":"Kiritsi","year":"2021","journal-title":"Front. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.abd.2020.05.001","article-title":"Inherited epidermolysis bullosa: Update on the clinical and genetic aspects","volume":"95","author":"Mariath","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_26","unstructured":"Pfendner, E.G., and Lucky, A.W. (1993). Dystrophic Epidermolysis Bullosa, University of Washington, Seattle."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: Pathogenesis and clinical features","volume":"28","year":"2010","journal-title":"Derm. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clindermatol.2011.03.012","article-title":"Inherited epidermolysis bullosa: New diagnostic criteria and classification","volume":"30","author":"Intong","year":"2012","journal-title":"Clin. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/humu.21576","article-title":"Kindler syndrome: Extension of FERMT1 mutational spectrum and natural history","volume":"32","author":"Has","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345615","article-title":"Introduction to Stem Cells and Regenerative Medicine","volume":"85","author":"Kolios","year":"2013","journal-title":"Respiration"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/stemcells.19-6-477","article-title":"Stem cells from the Mammalian blastocyst","volume":"19","author":"Rossant","year":"2001","journal-title":"Stem Cells"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12015-010-9170-1","article-title":"Pluripotent stem cells: Origin, maintenance and induction","volume":"6","author":"Alcaina","year":"2010","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10039-012-0020-z","article-title":"Pluripotent and multipotent stem cells in adult tissues","volume":"57","author":"Ratajczak","year":"2012","journal-title":"Adv. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.22203\/eCM.v020a11","article-title":"Mesenchymal stem cells: A perspective from in vitro cultures to in vivo migration and niches","volume":"20","author":"Augello","year":"2010","journal-title":"Eur. Cell Mater."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/stem.172","article-title":"Introducing transcription factors to multipotent mesenchymal stem cells: Making transdifferentiation possible","volume":"27","author":"Barzilay","year":"2009","journal-title":"Stem Cells"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10428190290011967","article-title":"Cell cycle regulation in human hematopoietic stem cells: From isolation to activation","volume":"43","author":"Marone","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/bies.201200063","article-title":"The emerging biology of muscle stem cells: Implications for cell-based therapies","volume":"35","author":"Bentzinger","year":"2013","journal-title":"Bioessays"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exphem.2004.11.005","article-title":"Stem cell biology and the plasticity polemic","volume":"33","author":"Quesenberry","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2217\/rme-2018-0019","article-title":"Advances in perinatal stem cells research: A precious cell source for clinical applications","volume":"13","author":"Abbaspanah","year":"2018","journal-title":"Regen. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/rep.1.00243","article-title":"Derivation, growth and applications of human embryonic stem cells","volume":"128","author":"Stojkovic","year":"2004","journal-title":"Reproduction"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.stem.2007.05.012","article-title":"Strategies and new developments in the generation of patient-specific pluripotent stem cells","volume":"1","author":"Yamanaka","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_44","unstructured":"Valarmathi, M.T. (2021). Surgical Treatment of Wounds Using Stem Cells in Epidermolysis Bullosa (EB), IntechOpen."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/bmb\/ldaa029","article-title":"Cellular therapy options for genetic skin disorders with a focus on recessive dystrophic epidermolysis bullosa","volume":"136","author":"Naso","year":"2020","journal-title":"Br. Med. Bull."},{"key":"ref_46","first-page":"143606","article-title":"Intravenous allogeneic umbilical cord blood\u2013derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients","volume":"6","author":"Lee","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_47","first-page":"151922","article-title":"Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Kiritsi","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFR\u03b1-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/exd.13979","article-title":"Epidermolysis bullosa: Advances in research and treatment","volume":"28","author":"Prodinger","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/bjd.17858","article-title":"Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts","volume":"181","author":"Ebens","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","article-title":"Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa","volume":"83","author":"Rashidghamat","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref_54","first-page":"1507","article-title":"Hologene 5: A Phase II\/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa","volume":"12","author":"Enzo","year":"2021","journal-title":"Front. Genet."},{"key":"ref_55","first-page":"e126243","article-title":"Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Lwin","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jid.2018.03.599","article-title":"591 A phase 1\/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB)","volume":"138","author":"Marinkovich","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13023-022-02546-9","article-title":"Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa","volume":"17","author":"So","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_58","first-page":"e130554","article-title":"Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa","volume":"4","author":"Eichstadt","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients with Recessive Dystrophic Epidermolysis Bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phoj.2019.09.002","article-title":"Bone marrow transplant for recessive dystrophic epidermolysis bullosa","volume":"4","author":"Khandelwal","year":"2019","journal-title":"Pediatr. Hematol. Oncol. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.10260","article-title":"Participation of bone marrow derived cells in cutaneous wound healing","volume":"196","author":"Badiavas","year":"2003","journal-title":"J. Cell Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0002-9440(10)63482-7","article-title":"Participation of adult mouse bone marrow cells in reconstitution of skin","volume":"163","author":"Kataoka","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMoa3461002","article-title":"Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells","volume":"346","author":"Katz","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(13)61897-8","article-title":"Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: Repair of the extracellular matrix","volume":"382","author":"Tolar","year":"2013","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jpeds.2015.05.051","article-title":"Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa","volume":"167","author":"Geyer","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2340\/00015555-3097","article-title":"Allogeneic Haematopoietic Cell Transplantation for Epidermolysis Bullosa: The Dutch Experience","volume":"99","author":"Yenamandra","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jid.2017.12.016","article-title":"EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure","volume":"138","author":"Uitto","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.TP.0000144325.01925.BE","article-title":"Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease","volume":"79","author":"Kopp","year":"2005","journal-title":"Transplantation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jid.2016.06.609","article-title":"Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa","volume":"136","author":"Hammersen","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in Clinical Development of Mesenchymal Stromal\/Stem Cells: Concise Review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: Cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa","volume":"23","author":"Mezger","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jcyt.2015.03.006","article-title":"Placenta-based therapies for the treatment of epidermolysis bullosa","volume":"17","author":"Lee","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.celrep.2015.08.010","article-title":"ABCB5 Identifies Immunoregulatory Dermal Cells","volume":"12","author":"Schatton","year":"2015","journal-title":"Cell Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/stem.3022","article-title":"Newly Defined ATP-Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron-Overload Wounds via Secretion of Interleukin-1 Receptor Antagonist","volume":"37","author":"Beken","year":"2019","journal-title":"Stem Cells"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/exd.14314","article-title":"Ex vivo gene modification therapy for genetic skin diseases\u2014Recent advances in gene modification technologies and delivery","volume":"30","author":"Jayarajan","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1089\/104303400750035825","article-title":"Toward Epidermal Stem Cell-Mediated ex Vivo Gene Therapy of Junctional Epidermolysis Bullosa","volume":"11","author":"Dellambra","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(75)80001-8","article-title":"Seria cultivation of strains of human epidemal keratinocytes: The formation keratinizin colonies from single cell is","volume":"6","author":"Rheinwatd","year":"1975","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00000658-200202000-00016","article-title":"Cultured Skin Substitutes Reduce Donor Skin Harvesting for Closure of Excised, Full-Thickness Burns","volume":"235","author":"Boyce","year":"2002","journal-title":"Ann. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jid.2018.11.036","article-title":"Gene Therapy for Epidermolysis Bullosa","volume":"139","author":"Marinkovich","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s13555-021-00561-5","article-title":"Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa","volume":"11","author":"Welponer","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"ref_91","first-page":"264ra164","article-title":"Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa","volume":"6","author":"Pasmooij","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Guo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Itoh, M., Umegaki-Arao, N., Guo, Z., Liu, L., Higgins, C.A., and Christiano, A.M. (2013). Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077673"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdermsci.2020.04.004","article-title":"Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR\/Cas9 and piggyBac transposon system","volume":"98","author":"Itoh","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/scrt246","article-title":"Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status","volume":"4","author":"Awe","year":"2013","journal-title":"Stem Cell Res. Ther."}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/10\/4\/422\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:04:07Z","timestamp":1760123047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/10\/4\/422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":99,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["bioengineering10040422"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering10040422","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]}}}